ArticleInvestigational new drugs2014

Phase I clinical and pharmacokinetic study of ombrabulin (AVE8062) combined with cisplatin/docetaxel or carboplatin/paclitaxel in patients with advanced solid tumors.

Rastislav Bahleda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.